LNG-encapsulated Injectable PLGA Microspheres

Product Overview

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Injectable

Duration Type: Long-acting

Description: Levonorgestrel (LNG) microspheres encapsulated in PLGA are fabricated to achieve longer duration of hormone release. PLGA with 50:50 and 85:15 lactic acid to glycolic acid copolymer ratios have been studied. An estimated 5 months would be required to deplete the initial drug load with these copolymer ratios.

Updated date: July 21, 2016

Vertical Tabs

Status

Project Phase: Early Development

Project Stage: Pre-clinical

Began discovery in: 2013

Download Product Report